NEW YORK (GenomeWeb News) – Molecular diagnostics products firm Claremont BioSolutions has signed deals to distribute its products in Europe, Taiwan, and South Korea.

The deals, announced on Thursday, are with Gentaur Molecular Products, based in Belgium; Ohhana Biotech in Taiwan; and Omics Biotech of South Korea, who will distribute Claremont's products for sample preparation, DNA isolation, and protein purification.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.